Radezolid

Research use only, not for human use.

Radezolid is a novel oxazolidinone antibiotic agent.

Radezolid is a novel oxazolidinone antibiotic agent.(In Vitro):Radezolid displays a greater potency than linezolid, independent of the bacteria tested, when concentrations are expressed on a weight (mg/L) basis. Radezolid shows an improved potency compared to that of linezolid when concentrations are expressed on a weight (mg/L) basis. Radezolid MICs are systematically equal to or lower (up to 3 log2 dilutions) than those of linezolid for all linezolid-susceptible strains, with an 8-fold difference for the linezolid-resistant strains. Radezolid and TR-700 perform well against 3-copy G2447T, G2576T, and G2576T/T2571C mutants .

RX-1741

GPCR/G Protein

Antibacterial

TNIK

——

——

869884-78-6

438.5

C22H23FN6O3

>98% (HPLC)

——

CC(=O)NC[C@H]1CN(C(=O)O1)c1ccc(c(F)c1)-c1ccc(CNCc2cnn[nH]2)cc1

——

(-20℃)

With Ice Pack

≥ 2 years